Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUSEC trial of oral cannabis extract for multiple sclerosis spasticity symptoms
ISRCTN42223114Phase 3Completed
- Sponsor
- The Institute of Cancer Research
- Start
- Jun 2006
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in multiple sclerosis (MS) comparing Cannabis extract with Placebo (2 arms). Primary endpoint: Change in muscle stiffness. Started Jun 2006; status: completed.
02
Drugs
cannabis extract
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on ISRCTN42223114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN42223114.